|

Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy

RECRUITINGSponsored by Soochow University
Actively Recruiting
SponsorSoochow University
Started2025-03-31
Est. completion2026-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06882577

Summary

Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy. This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Written informed consent by patient
2. Age ≥ 18 years
3. Acute ischemic stroke (with matching brain lesion on MR imaging)
4. Enrolment within 24 h after onset of stroke-related symptoms.

Exclusion Criteria:

1. Pregnancy and / or breast-feeding.
2. Participation in an interventional study.
3. Patients refuse to participate in the research.

Conditions2

Acute Ischemic StrokeHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.